Phenformin in Insulin-Dependent Diabetics
- 14 March 1970
- Vol. 1 (5697) , 660-662
- https://doi.org/10.1136/bmj.1.5697.660
Abstract
Forty-one diabetic patients on insulin were given 100mg. of phenformin daily for six weeks, either before or after a period of six weeks of inert capsules, in a double-blind cross-over trial. Eleven patients while on phenformin noticed hypoglycaemic effects and reduced their insulin on average by almost 20% without resultant rise in blood sugar levels. Twenty-eight patients felt no untoward effects and maintained their usual insulin dose. Phenformin led to improved control of the diabetes, with a significant decrease in blood sugar levels and a significant reduction in the variability of the weekly blood sugar readings. There was no increased ketosis, no change in cholesterol, and no significant loss of weight.Keywords
This publication has 11 references indexed in Scilit:
- HYPERLIPIDEMIAAnnals of the New York Academy of Sciences, 1968
- INFLUENCE OF HYPOGLYCEMIC THERAPY ON BLOOD LIPIDS AND BODY WEIGHT IN DIABETES MELLITUSAnnals of the New York Academy of Sciences, 1968
- INFLUENCE OF HYPOGLYCEMIC AGENTS ON BLOOD LIPIDS AND BODY WEIGHT IN KETOACIDOSIS-RESISTANT DIABETICSAnnals of the New York Academy of Sciences, 1968
- PHENFORMIN EFFECT ON BODY WEIGHT, LIPIDS, AND GLUCOSE REGULATIONAnnals of the New York Academy of Sciences, 1968
- Relation of the complications of diabetes to the clinical state.1967
- The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabeticMetabolism, 1966
- Automated determination of serum total cholesterolClinica Chimica Acta; International Journal of Clinical Chemistry, 1964
- PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICSThe Lancet, 1964
- Oral Treatment of DiabetesBMJ, 1958
- Clinical Report of a New Hypoglycemic AgentExperimental Biology and Medicine, 1957